论文信息 - First-in-human use of a modular capsid virus-like vaccine platform: an open-label, non-randomised, phase 1 clinical trial of the SARS-CoV-2 vaccine ABNCoV2 - 字舞流文

First-in-human use of a modular capsid virus-like vaccine platform: an open-label, non-randomised, phase 1 clinical trial of the SARS-CoV-2 vaccine ABNCoV2

H. Wertheim | J. Bukh | S. Justesen | T. Theander | H. Wertheim | B. Mordmüller | P. Kremsner | S. Paludan | Meral Esen | R. Fendel | A. Salanti | M. Nielsen | K. Teelen | R. ter Heine | M. McCall | Stine B. Clemmensen | W. A. de Jongh | A. Sander | A. Kreidenweiss | T. Gustavsson | Daniel S. Jensen | T. Lança | Louise Goksøyr | Alexander P. Underwood | M. Idorn | R. Dagil | Mette Hamborg | S. Ramirez | Constanze Heinzel | Cyrielle Fougeroux | E. Vidal-Calvo | Paul Khalifé | T. Hulen | M. Ariaans | M. Smit | Max Soegaard | Alekxander Binderup | M. Esen | C. Janitzek | S. M. Erdoğan | Olivia Lie-Andersen | Merel J Adam F Maud B P A Cyrielle Constanze Rolf Meral Smit Sander Ariaans Fougeroux Heinzel Fende | Søren Riis Paludan | Heiman Frank Louis Wertheim | Rolf Fendel | Jens Bukh | Morten A Nielsen | Peter G. Kremsner | B. Mordmüller | M. B. B. McCall | Maud B P A Ariaans | Rob ter Heine | Alexander P Underwood | Mette Hamborg | Alexander P. Underwood